Clearview Capital has acquired Northwest Cosmetic Laboratories, a maker of cosmetic and skin care products for branded cosmetic and personal care companies. Clearview made the acquisition in partnership with company management. Gary Voigt, Northwest Cosmetic’s owner, will remain a significant investor. The deal marks Clearview’s third platform investment from Fund III in the last six months.
Clearview Capital Fund III, L.P. (“Fund III”) announced today the acquisition, in partnership with management, of Northwest Cosmetic Laboratories, LLC (“NCL” or the “Company”), a rapidly growing formulator and manufacturer of innovative cosmetic and skin care products for leading branded cosmetic and personal care companies.
Headquartered in Idaho Falls, Idaho, NCL specializes in formulating “physician strength” skincare and prestige cosmetic products, which
are growing categories benefitting from new ingredient technologies and shifting consumer preferences for anti-aging and other cosmetic or health benefits. NCL has leveraged its product development expertise and industry-leading reputation for quality and customer service to
develop an outstanding group of customers that include boutique and internationally-recognized brands, specialty retailers and other personal care companies that distribute through a diverse mix of retail, internet and direct marketing channels.
Gary Voigt, NCL’s owner, will remain a significant investor and active on the board of directors, and the Company will continue to be led by its current management team including its CEO, Matt Bryant.
“We are very enthusiastic about our new partnership with Clearview,” said Mr. Voigt. “NCL has significant growth opportunities ahead and Clearview Capital has the experience and resources to help us reach the next level while also preserving the culture that has made us successful.”
“We are thrilled to be working with Gary, Matt and the entire NCL team,” said Calvin Neider, Managing Partner of Clearview Capital. “NCL has many attractive avenues of growth which we intend to pursue, and we look forward to supporting the Company as it seeks to expand into new product categories and markets, both organically and potentially through acquisition.”
NCL marks Fund III’s third platform investment in the last six months and the ninth acquisition for all Clearview Capital funds in the past twelve months. Clearview Capital’s other holdings include Novik, Inc., a leading manufacturer of innovative polymer exterior siding and roofing products; St. Croix Hospice, LLC, a provider of high quality, palliative care for hospice patients; QC Supply, LLC, a leading wholesale distributor to the swine and poultry markets; Battenfeld Technologies, Inc., a designer, developer and supplier of branded shooting and hunting accessories to the outdoor sporting goods industry; GCR, Inc., a professional services firm delivering consulting services and technology solutions to governmental and commercial clients; Child Health Holdings, Inc. d.b.a. Pediatric Health Choice, the country’s largest provider of prescribed pediatric extended care (“PPEC”) centers for medically complex children; Pyramid Healthcare, Inc., a provider of substance abuse and mental health treatment programs for adults and adolescents; The Results Companies, LLC, a rapidly growing provider of customer relationship management solutions; QualSpec Group, a provider of mechanical integrity inspection and non-destructive examination services to the refining, petrochemical, power generation and other industries; and Senior Care/Active Day, the country’s largest operator of adult day care centers.